J
Jana Lizrova Preiningerova
Researcher at Charles University in Prague
Publications - 33
Citations - 2000
Jana Lizrova Preiningerova is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 13, co-authored 26 publications receiving 1761 citations. Previous affiliations of Jana Lizrova Preiningerova include First Faculty of Medicine, Charles University in Prague & Yale University.
Papers
More filters
Journal ArticleDOI
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Timothy Vollmer,L. Lyndon Key,Valerie Durkalski,William R. Tyor,William R. Tyor,John R. Corboy,John R. Corboy,Silva Markovic-Plese,Jana Lizrova Preiningerova,Jana Lizrova Preiningerova,Marco A. Rizzo,Inderjit Singh +11 more
TL;DR: Investigation of use of oral simvastatin in 30 individuals with relapsing-remitting multiple sclerosis found it to inhibit inflammatory components of multiple sclerosis that lead to neurological disability.
Journal ArticleDOI
Prevalence and treatment of spasticity reported by multiple sclerosis patients
TL;DR: In the focused survey, ITBG reported lower levels of spasticity than ORALG, less stiffness in the legs, less pain and fewer spasms at any time, which can significantly impact QOL parameters by reducing spasms, pain and fatigue.
Journal ArticleDOI
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Elena H. Martinez-Lapiscina,Sam Arnow,James A. Wilson,Shiv Saidha,Jana Lizrova Preiningerova,Timm Oberwahrenbrock,Alexander U. Brandt,Luis E. Pablo,Simone Guerrieri,Ines Gonzalez,Olivier Outteryck,Ann Kristin Mueller,P. Albrecht,Wesley Chan,Sebastian Lukas,Lisanne J. Balk,Clare L. Fraser,Jette L. Frederiksen,Jennifer Resto,Teresa C. Frohman,Christian Cordano,Irati Zubizarreta,Magi Andorra,Bernardo Sanchez-Dalmau,Albert Saiz,Robert A. Bermel,Alexander Klistorner,Axel Petzold,Sven Schippling,Fiona Costello,Orhan Aktas,Patrick Vermersch,Celia Oreja-Guevara,Giancarlo Comi,Letizia Leocani,Elena García-Martín,Friedemann Paul,Eva Havrdova,Elliot M. Frohman,Laura J. Balcer,Laura J. Balcer,Ari J. Green,Peter A. Calabresi,Pablo Villoslada,Pablo Villoslada +44 more
TL;DR: The results provide evidence of the usefulness of monitoring peripapillary retinal nerve fibre layer thickness by OCT for prediction of the risk of disability worsening with time in patients with multiple sclerosis.
Journal ArticleDOI
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate:
Corey C. Ford,Andrew D. Goodman,Kenneth P. Johnson,Norman J Kachuck,J. W. Lindsey,Robert P. Lisak,Christopher Luzzio,Lawrence W. Myers,Hillel Panitch,Jana Lizrova Preiningerova,A. A. Pruitt,John W. Rose,Horea Rus,Jerry S. Wolinsky +13 more
TL;DR: In conclusion, multiple sclerosis patients with mean disease duration of 22 years administering GA for up to 15 years had reduced relapse rates, and decreased disability progression and transition to SPMS.
Journal ArticleDOI
Transplantation of Cryopreserved Adult Human Schwann Cells Enhances Axonal Conduction in Demyelinated Spinal Cord
Ikuhide Kohama,Karen L. Lankford,Jana Lizrova Preiningerova,Fletcher A. White,Timothy Vollmer,Jeffery D. Kocsis +5 more
TL;DR: The conclusion that transplantation of human Schwann cells results in functional remyelination of a dorsal column lesion of immunosuppressed Wistar rat is supported.